Everything you should know about 100l Bioreactor Pichia pastoris!

time2024/11/15

Overview of Pasteur Pichia pastoris and Laboratory Bioreactor cell Culture Bioreactor Bioreactor

stainless fermenter

1、 Background of Pasteur Pichia pastoris Pasteur Pichia pastoris (hereinafter referred to as Pichia pastoris) is a type of methanol tolerant yeast isolated by Herman Phaff from oak trees in 1956, named Pichia pastoris. It was reclassified as Komagataella in 1995 and later subdivided into two species: Komagataella pastoris and Komagataella phaffii. At present, the widely used commercial strains X33 and GS115 of Pichia pastoris belong to K Phaffii species, but most literature and databases still use the old name P pastoris.


stirred tank bioreactor

The methanol metabolism pathway of Pichia pastoris: methanol is oxidized to formaldehyde and hydrogen peroxide through alcohol oxidase (AOX1/2). Hydrogen peroxide (H2O2) is catalyzed by catalase (CAT) to decompose into water and oxygen, while formaldehyde has two destinations: a portion of formaldehyde enters the assimilation pathway and is assimilated in the dihydroxyacetone synthase (Das1/Das2) and xylulose monophosphate cycle, regenerating 3-ketose-5-phosphate molecules and constructing a glyceraldehyde-3-phosphate as a precursor for biomass formation; The other part enters the pathway of alienation, where formaldehyde is oxidized to formic acid to generate CO2, producing cytoplasmic NADH, which can be used as a reducing equivalent or enter the respiratory chain to provide ATP.


1 gallon fermenter


Phenotype of Pichia pastoris: In the expression system of Pichia pastoris, there are two genes encoding alcohol oxidase, namely AOX1 and AOX2. The expression level of AOX2 is much lower than that of AOX1, and the activity of alcohol oxidase in cells is mainly provided by the AOX1 protein expressed by the AOX1 gene. Based on the presence or absence of two alcohol oxidase genes, there are three different methanol utilization (Mut) phenotypes, and the wild-type with active AOX1 and AOX2 is called Mut+; When the AOX1 gene is lost and only AOX2 exists, most of the alcohol oxidase activity is lost. This type of cell has a low ability to utilize methanol and grows slowly on methanol culture medium. The phenotype of the strain is MutS (Methanol Utilization Slow), and MutS yeast strain has a mutated aox1 site, but AOX2 is wild-type; And in strains where both AOX genes are missing, it is called Mut −.


2、 The tools and techniques for expressing recombinant proteins in Pichia pastoris play an important role in the process of recombinant protein production using mature and constantly expanding tools and techniques, enabling P Pastoris becomes an efficient expression system.


30 gallon fermenter


2.1 The various strains of Pasteur Pichia pastoris currently used as host strains are all derived from the original Y-11430 strain, and the selection of strains includes wild-type, nutritionally deficient, protease deficient, and sugar engineered strains (Table 1). When proteins are expressed intracellular, MutS phenotype can be prioritized, and both Mut+and MutS can be used for secretion expression. Most yeast strains such as SMD1168, GS115, KM-71 are histidine dehydrogenase deficient and can be screened for recombinants using histidine free media. SMD1168 is a protease deficient type, suitable for situations where it is necessary to protect expressed proteins from endogenous protease degradation, such as unstable proteins or protein complexes.


In yeast expression systems, the plasmids or vectors used for transformation often do not contain the replication source points of yeast itself. If the circular recombinant plasmid is directly transferred into yeast cells, it cannot exist stably. Therefore, linearization treatment must be carried out to integrate it into yeast chromosomes through homologous recombination, so that the target gene can exist stably in yeast cells. The expression vectors of yeast expression system are mainly integrated vectors, which commonly include intracellular protein expression and secreted protein expression. Intracellular expression vectors: mainly including pGAPZ, pPIC3, pPICZ, pPSC3K, pHIL-D2, etc. Expressing the target gene inside the cell can avoid yeast glycosylation and is suitable for cytoplasmic expression or protein expression without glycosylation. The expression level is higher than that of extracellular secretion, but purification is relatively complex. The vectors secreted for extracellular expression include pPIC9, pHIL-S1p, pPICZ α, pYAM75P, etc. Multi copy insertion expression vectors: pPIC9K, pPIC3.5K. Multi copy integration of recombinant genes can increase protein expression levels.


50 gallon fermenter

2.3 Promoter Pichia pastoris provides a variety of well characterized constitutive and inducible promoters for selection. Constituent promoters provide simplicity and relatively constant expression levels, while inducible promoters are commonly used when isolation, growth, and production are required, which can prevent fast-growing non recombinant cells or the production of toxic proteins (Table 3). Constituent promoters such as pGAP and pGCW14 are commonly used for large-scale recombinant protein production, but are not suitable for expressing proteins that are toxic to cells. Induced promoters such as pAOX1 are strong inducible promoters that are highly activated in the presence of methanol to efficiently drive the expression of target genes, making them suitable for large-scale production; PFLD1 can induce the expression of recombinant FLD1 protein using methanol or methylamine, and glycerol or glucose can replace methanol. The toxicity of methanol has prompted extensive research on expression systems that do not rely on methanol, such as pGTH1 induction under glucose restriction conditions, which promotes metabolic transformation of cells under specific culture conditions, thereby increasing the yield of target products; PTHI11 is activated at low concentrations of thiamine and regulates gene expression by adjusting the concentration of thiamine; PADH3 drives gene expression in the presence of ethanol as a carbon source.


bioreactor for sale

2.4 Signal peptides and stop signal peptides help locate target proteins to the secretion pathway of cells, ensuring their correct folding and subsequent modification, which is crucial for high-level expression and secretion of functional proteins. The commonly used signal peptides in Pichia pastoris include the α - Mating Factor (α - MF) of brewing yeast, Sucrose Converting Enzyme 2 (SUC2), and Pichia pastoris Acid Phosphatase (PHO1). α - MF is the most commonly used and is mainly used for the secretion and expression of peptides and small proteins. Researchers have discovered four new endogenous signal peptides in the reported protein and genome secreted by Pichia pastoris: Dan 4, Gas 1, Msb 2, and Fre 2, expanding the signal peptide library available for recombinant protein expression and secretion in Pichia pastoris.


The termination subregion can affect expression levels, and the termination toolbox in Pichia pastoris only contains 20 termination codons with little change in expression. At present, research has developed and characterized a directory containing 72 endogenous, heterogeneous, and synthetic termination sub directories, in which 17 fold tunability has been observed. The new termination sub directory provides more choices and regulatory capabilities.
The mature molecular biology technology of CRISPR/Cas9 has accelerated the process of Pichia pastoris strain formation. GoldenPiCS is a modular cloning tool that simplifies the process of cloning and constructing recombinant vectors, allowing multiple genes to be quickly assembled in a single vector and integrated into the host cell genome. This method enhances the copy number of recombinant genes by selectively labeling and increasing selection pressure, thereby increasing protein production. The application of new technologies such as CRISPR/Cas9 in P Precise editing of the Pastoris genome, including gene knockout, insertion, and replacement. By knocking out inhibitory genes or enhancing the expression of key genes, P. can be improved The yield of recombinant proteins in pasta. Using CRISPR/Cas9 for metabolic engineering modification of P The metabolic pathway of pasta enhances the production of specific metabolites, such as enzymes or compounds; It can also achieve marker free genome integration, avoiding the use of resistance markers and reducing potential negative effects on cells; Support simultaneous targeting of multiple genes, enabling P Performing complex genome editing and engineering in Pastoris has become more efficient. Continuously optimizing CRISPR/Cas9 in P The application of Pastoris, including improving editing efficiency and reducing off target effects, further promotes P The application of pasta in fields such as biomedicine, industrial enzyme production, and metabolic engineering.

3、 The application of Pichia pastoris in recombinant proteins. As a host for recombinant protein production, Pichia pastoris covers multiple fields such as biomedicine, industrial enzymes, and emerging markets, demonstrating its versatility and adaptability.

In the field of biomedicine, the Pichia pastoris expression system is widely used in the production of various recombinant protein drugs, such as antibodies, vaccines, etc. In 2018, Caplacizumab, an antibody drug used to treat adult acquired thrombotic thrombocytopenic purpura, was approved for market by the European Union's EMA. This is the first nanobody drug produced using the Pichia pastoris expression system. On February 21, 2020, the FDA approved the marketing of Eptinezumab from Denmark's Lingbei Pharmaceuticals, which is the first monoclonal antibody drug expressed in Pichia pastoris. Eptinezumab is a humanized IgG1 monoclonal antibody against CGRP, expressed in Pichia pastoris through recombinant DNA technology, and blocked N-glycosylation by site directed mutagenesis to alter glycosylation sites, solving the immunogenicity problem of specific high mannose chains. In May 2022, Watson Biosciences obtained market approval for the world's first bivalent human papillomavirus vaccine expressed in Pichia pastoris - Wozehui. Wozehui uses Pichia pastoris, which has more production capacity advantages and lower costs than Merck's brewing yeast expression system, which has 4-valent and 9-valent vaccines. In August 2024, the quadrivalent recombinant norovirus vaccine (Pichia pastoris) developed by Zhifei Biotechnology entered phase III clinical trials. The vaccine secretes virus like particles expressing norovirus proteins in the Pichia pastoris expression system through genetic engineering technology. Pichia pastoris has many advantages. Firstly, both Pichia pastoris and CHO cells are eukaryotic cells, possessing many advantages of advanced eukaryotic expression systems; Secondly, the construction of Pichia pastoris cell lines is faster and does not require time-consuming virus clearance validation steps, greatly shortening the research and development cycle; Finally, in terms of production, Pichia pastoris has the characteristics of faster, easier, cheaper, and higher yield. It can also be cultured at high density and on a large scale, significantly reducing the production cost of antibody drugs. So far, Pichia pastoris has been favored by more and more research institutions and pharmaceutical manufacturers. Many protein drugs, such as insulin, hepatitis B surface antigen, human serum albumin, epidermal growth factor, tumor necrosis factor, etc., have used the yeast expression system for protein expression and come into the market.
In the field of basic research, various recombinant proteins and their mutants are expressed using the Pichia pastoris expression system to study protein structures, protein-protein interactions, biochemical characteristics, and biophysical studies. High resolution crystal structures of various penicillinases were obtained through expression in Pichia pastoris, which is crucial for understanding their catalytic mechanisms. The expression of GPCRs and other transporters in Pichia pastoris greatly enhances our understanding of their functions and substrate transport mechanisms. Pichia pastoris is the preferred host for isotope labeled proteins, suitable for NMR structural analysis. Various labeling strategies used in research, such as 13C, 15N, 19F labeling, have improved spectral resolution and sensitivity.

Conclusion: Pichia pastoris is the preferred expression platform for recombinant protein production, with advantages such as efficient expression system, high cell density growth, high-level recombinant protein production, diverse post-translational modifications, simplified purification process, and safety without endotoxins and viruses. Pichia pastoris has multiple constitutive and inducible promoters, which can precisely control gene expression under different culture conditions, thereby achieving efficient production of recombinant proteins. However, challenges such as methanol toxicity, protein hydrolysis and truncation, limitations of basic research tools, and insufficient expression levels still need to be overcome.


The application of genome editing technologies such as CRISPR/Cas9 will improve the efficiency of homologous recombination. The development of promoter engineering can develop new promoters or improve existing promoters to enhance expression levels and regulatory capabilities. Through glycosylation engineering, Pichia pastoris can produce recombinant proteins with highly uniform human N-linked sugar chains, enhancing their potential in biopharmaceutical applications. Through continuous research and technological innovation, Pichia pastoris is expected to solve existing challenges in the future and achieve more efficient and safe production of recombinant proteins.

7 gallon fermenter